Library/Regulatory
Regulatory · 4 min

ITC receives mammography 337 complaints: DN 3951-3952

Public inspection Nov 19; scheduled FR publication Nov 20. Filed Nov 16. Public interest comments eight calendar days after publication.

Cover illustration: ITC receives mammography 337 complaints: DN 3951-3952

The U.S. International Trade Commission received two Section 337 complaints involving mammography systems and is soliciting public interest comments (FR Docs. 2026-23619 and 2026-23627). Both notices were filed for Federal Register public inspection on November 19, 2026 at 8:45 a.m. and are scheduled for publication on November 20, 2026. Complaints filed November 16, 2026. Issued November 17, 2026, Lisa Barton, Secretary to the Commission. These are complaint receipts only; the Commission has not instituted investigations. Authority: 19 U.S.C. 1337; 19 CFR 210.8. Public complaint materials are on EDIS.

DN 3951 (Hologic v. Siemens entities) and DN 3952 (Siemens Medical Solutions USA v. Hologic). Cross-filed mammography complaints. Not instituted. Public interest comments due eight calendar days after FR publication.

FR Docs. 2026-23619 / 2026-23627 · DN 3951 / DN 3952 · public inspection Nov 19, 2026 · scheduled FR publication Nov 20, 2026 · filed Nov 16, 2026 · issued Nov 17, 2026
DN 3951: Hologic, Inc. · Certain Mammography Systems with Focal Spot Compensation Technology and Components Thereof, Including X-Ray Tubes · Siemens Healthineers AG; Siemens Healthcare GmbH; Siemens Medical Solutions USA, Inc. (Malvern, PA)
DN 3952: Siemens Medical Solutions USA, Inc. · Certain Mammography Systems and Components Thereof · Hologic, Inc. (Marlborough, MA)

DN 3951: Hologic complaint

Filed on behalf of Hologic, Inc. Title: Certain Mammography Systems with Focal Spot Compensation Technology and Components Thereof, Including X-Ray Tubes. Named respondents: Siemens Healthineers AG of Germany; Siemens Healthcare GmbH of Germany; and Siemens Medical Solutions USA, Inc. of Malvern, PA. The complainant requests a limited exclusion order, cease and desist orders, and a bond during the 60-day Presidential review period under 19 U.S.C. 1337(j). The notices do not list patent numbers.

DN 3952: Siemens Medical Solutions USA complaint

Filed on behalf of Siemens Medical Solutions USA, Inc. Title: Certain Mammography Systems and Components Thereof. Named respondent: Hologic, Inc. of Marlborough, MA. The complainant likewise requests a limited exclusion order, cease and desist orders, and a bond during the 60-day Presidential review period under 19 U.S.C. 1337(j). A separate earlier Library item covers four other recent Section 337 complaint receipts (DN 3946-3949) (Section 337 complaints DN 3946-3949).

Public interest comments

Under 19 CFR 210.8(b), proposed respondents, other interested parties, members of the public, and interested government agencies may comment on public interest issues. Comments should address whether the requested relief would affect U.S. public health and welfare, competitive conditions, production of like or directly competitive articles, or U.S. consumers. The Commission is particularly interested in comments that: (i) explain how the articles potentially subject to the requested orders are used in the United States; (ii) identify public health, safety, or welfare concerns relating to the requested orders; (iii) identify like or directly competitive articles made in the United States that could replace excluded articles; (iv) indicate whether complainant, licensees, and/or third-party suppliers can replace the volume of articles potentially subject to exclusion or cease-and-desist relief within a commercially reasonable time; and (v) explain how the requested orders would impact U.S. consumers.

  • Deadline: written submissions due by close of business eight calendar days after Federal Register publication (scheduled for November 20, 2026).
  • Replies: complainants may file replies three calendar days after the written-submission due date.
  • Length: five pages inclusive of attachments.
  • Filing: electronic filings through EDIS; reference Docket No. 3951 or 3952 prominently.

What happens next

The Commission will decide whether to institute investigations. No investigation has been instituted yet, and no exclusion order exists. Hospital systems, imaging distributors, and importers of mammography systems and x-ray tubes should watch for institution notices and any later remedial orders before changing entry practices.

Drawback note

These are complaints only. No investigation has been instituted and no exclusion order exists. A possible future exclusion order would bar entry of infringing articles rather than change duties.

Key takeaways
  • FR Docs. 2026-23619 and 2026-23627: ITC received DN 3951 and DN 3952 mammography Section 337 complaints filed Nov 16, 2026. Public inspection Nov 19, 2026; scheduled FR publication Nov 20, 2026.
  • DN 3951: Hologic, Inc. vs Siemens Healthineers AG, Siemens Healthcare GmbH, and Siemens Medical Solutions USA, Inc. (Malvern, PA). Focal spot compensation technology, including x-ray tubes.
  • DN 3952: Siemens Medical Solutions USA, Inc. vs Hologic, Inc. (Marlborough, MA). Mammography systems and components.
  • Each complainant requests LEO, cease and desist orders, and a 1337(j) bond. Public interest comments due eight calendar days after FR publication; replies three calendar days later; five-page limit.
  • Not instituted. A possible future exclusion order would bar entry of infringing articles rather than change duties.
Primary sources
  1. Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest (DN 3951; FR Doc. 2026-23619) · Federal Register / U.S. International Trade Commission
  2. Public inspection PDF: FR Doc. 2026-23619 · Federal Register
  3. Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest (DN 3952; FR Doc. 2026-23627) · Federal Register / U.S. International Trade Commission
  4. Public inspection PDF: FR Doc. 2026-23627 · Federal Register
  5. 19 U.S.C. 1337 · Legal Information Institute
  6. 19 CFR 210.8 · eCFR
  7. EDIS · USITC
DA
DrawbackAI Team
We build software for the US duty drawback program — so the refund isn't reserved for billion-dollar importers and the firms that charge 30% to find it.

This article is for general information and is not legal or tax advice. Drawback eligibility depends on your specific facts, and final refunds are determined by CBP at liquidation. Consult a licensed customs broker or attorney for your situation.

Find out what you're owed.

Upload your imports and exports. Get a defensible estimate in under 10 minutes. No card required.

Get free estimate